Effects of Consuming Sugar-Sweetened Beverages With Meals for 10 Weeks
NCT ID: NCT01165853
Last Updated: 2017-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2005-07-31
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Metabolic Effects of Consuming Sugar-Sweetened Beverages for Two Weeks
NCT01103921
Adverse Metabolic Effects of Dietary Sugar
NCT02548767
The Effect of Sugar Sweetened and Diet Beverages Consumed as Part of a Weight-Maintenance Diet on Fat Storage
NCT02252952
Acute Effects of Artificial Sweeteners or Sugar on Hemodynamic and Metabolic Stress Responses
NCT02973334
Short-term Sugary Beverage Consumption on Glucose Control and Cardiovascular Disease Risk Factors
NCT04118257
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Glucose
Glucose
25% dose at 8-week intervention assigned to subjects.
Fructose
Fructose
25% dose at 8-week intervention assigned to subjects.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Glucose
25% dose at 8-week intervention assigned to subjects.
Fructose
25% dose at 8-week intervention assigned to subjects.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women were post-menopausal based on a self-report of no menstruation for at least one year
Exclusion Criteria
* renal or hepatic disease
* fasting serum TG concentrations \>400 mg/dl
* hypertension (\>140/90 mg Hg)
* surgery for weight loss
* individuals who smoked
* reported exercise of more than 3.5 hours/week at a level more vigorous than walking
* having used thyroid, lipid-lowering, glucose-lowering, anti-hypertensive, anti-depressant, or weight loss medications
* habitual ingestion of more than one sugar-sweetened beverage/day or more than two alcoholic beverages/day
40 Years
72 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter J Havel, D.V.M.
Role: PRINCIPAL_INVESTIGATOR
University of California, Davis
Kimber L Stanhope, Ph.D, R.D.
Role: STUDY_DIRECTOR
University of California, Davis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Research Center
Sacramento, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Law HG, Stanhope KL, Zhang W, Myagmarsuren M, Jamshed ZM, Khan MA, Bang H, Havel PJ, Berglund L, Enkhmaa B. Lipoprotein(a) and diet: consuming sugar-sweetened beverages lowers lipoprotein(a) levels in obese and overweight adults. J Lipid Res. 2024 Aug;65(8):100588. doi: 10.1016/j.jlr.2024.100588. Epub 2024 Jul 4.
Cox CL, Stanhope KL, Schwarz JM, Graham JL, Hatcher B, Griffen SC, Bremer AA, Berglund L, McGahan JP, Keim NL, Havel PJ. Circulating concentrations of monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, and soluble leukocyte adhesion molecule-1 in overweight/obese men and women consuming fructose- or glucose-sweetened beverages for 10 weeks. J Clin Endocrinol Metab. 2011 Dec;96(12):E2034-8. doi: 10.1210/jc.2011-1050. Epub 2011 Sep 28.
Stanhope KL, Griffen SC, Bremer AA, Vink RG, Schaefer EJ, Nakajima K, Schwarz JM, Beysen C, Berglund L, Keim NL, Havel PJ. Metabolic responses to prolonged consumption of glucose- and fructose-sweetened beverages are not associated with postprandial or 24-h glucose and insulin excursions. Am J Clin Nutr. 2011 Jul;94(1):112-9. doi: 10.3945/ajcn.110.002246. Epub 2011 May 25.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
200412368
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.